×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Blood Bag Market

ID: MRFR/HC/40563-HCR
200 Pages
Garvit Vyas
February 2026

Blood Bag Market Research Report By Type (Plastic Blood Bags, Multi-Chamber Blood Bags, Transfer Packs), By Application (Whole Blood Collection, Component Collection, Blood Storage), By End Use (Hospitals, Blood Banks, Clinics), By Material (Polyvinyl Chloride, Polyolefin, Ethylene Vinyl Acetate) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Blood Bag Market Infographic
Purchase Options

Blood Bag Market Summary

As per Market Research Future analysis, the Blood Bag Market Size was estimated at 4.49 USD Billion in 2024. The Blood Bag industry is projected to grow from USD 4.643 Billion in 2025 to USD 6.493 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 3.41% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Blood Bag Market is experiencing robust growth driven by technological advancements and increasing demand for blood products.

  • North America remains the largest market for blood bags, driven by advanced healthcare infrastructure and high demand.
  • Asia-Pacific is emerging as the fastest-growing region, fueled by increasing healthcare investments and rising awareness of blood donation.
  • Plastic blood bags dominate the market, while multi-chamber blood bags are witnessing rapid growth due to their efficiency in component collection.
  • Technological advancements and regulatory compliance are key drivers, supporting the rising demand for blood products across various segments.

Market Size & Forecast

2024 Market Size 4.49 (USD Billion)
2035 Market Size 6.493 (USD Billion)
CAGR (2025 - 2035) 3.41%

Major Players

Terumo Corporation (JP), Haemonetics Corporation (US), Grifols S.A. (ES), Macopharma (FR), Fresenius Kabi AG (DE), Baxter International Inc. (US), Blood Systems Inc. (US), Kawasumi Laboratories Inc. (JP), Medtronic plc (IE)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Blood Bag Market Trends

The Blood Bag Market is currently experiencing a dynamic evolution, driven by advancements in medical technology and increasing demand for safe blood transfusions. The growing awareness regarding the importance of blood donation and the need for efficient blood storage solutions are contributing to the market's expansion. Furthermore, regulatory bodies are emphasizing stringent quality standards, which is likely to enhance the safety and efficacy of blood bags. This focus on quality may lead to innovations in materials and designs, potentially improving the overall performance of blood storage systems. In addition, the Blood Bag Market appears to be influenced by the rising prevalence of chronic diseases and the aging population, which necessitates a higher volume of blood transfusions. Hospitals and blood banks are increasingly adopting automated systems for blood collection and storage, indicating a shift towards more efficient operational practices. As the market continues to evolve, it is essential to monitor these trends closely, as they may shape the future landscape of blood bag technology and usage.

Technological Advancements

The Blood Bag Market is witnessing a surge in technological innovations, particularly in materials and manufacturing processes. Newer blood bag designs are being developed to enhance safety and reduce the risk of contamination. These advancements may lead to improved shelf life and better storage conditions, which are crucial for maintaining blood quality.

Regulatory Compliance

There is an increasing emphasis on regulatory compliance within the Blood Bag Market. Regulatory agencies are implementing stricter guidelines to ensure the safety and efficacy of blood bags. This trend may drive manufacturers to invest in quality assurance processes, thereby enhancing product reliability and consumer trust.

Rising Demand for Blood Products

The demand for blood products is on the rise, driven by an increase in surgical procedures and trauma cases. This trend suggests that blood banks and healthcare facilities will require more efficient blood bag solutions to meet the growing needs of patients. Consequently, manufacturers may focus on developing versatile blood bag systems that cater to diverse medical applications.

Blood Bag Market Drivers

Regulatory Compliance in Blood Bag Market

Regulatory compliance plays a crucial role in shaping the Blood Bag Market. Stringent regulations imposed by health authorities ensure that blood bags meet safety and quality standards. Compliance with these regulations not only protects patients but also enhances the credibility of manufacturers. The industry is subject to various guidelines, including those related to materials used in blood bag production and the processes involved in blood collection and storage. As a result, manufacturers are investing in quality assurance and control measures to adhere to these regulations. This focus on compliance is expected to drive market growth, as hospitals and blood banks prefer suppliers that meet or exceed regulatory standards. The Blood Bag Market is thus likely to expand as compliance becomes increasingly integral to operational strategies.

Technological Advancements in Blood Bag Market

The Blood Bag Market is experiencing a notable transformation due to technological advancements. Innovations in materials and manufacturing processes are enhancing the safety and efficiency of blood storage and transportation. For instance, the introduction of sterile, single-use blood bags has reduced the risk of contamination, thereby improving patient outcomes. Furthermore, advancements in blood bag design, such as the incorporation of integrated blood filters, are streamlining transfusion processes. According to recent data, the market for blood bags is projected to grow at a compound annual growth rate of approximately 6.5% over the next five years, driven by these technological improvements. As hospitals and blood banks increasingly adopt these advanced solutions, the Blood Bag Market is likely to witness significant growth.

Emerging Markets and Expansion in Blood Bag Market

Emerging markets are presenting new opportunities for growth within the Blood Bag Market. As healthcare infrastructure improves in developing regions, there is a growing need for reliable blood storage solutions. Countries with expanding healthcare systems are increasingly investing in blood banks and transfusion services, which drives the demand for blood bags. Market data suggests that regions such as Asia-Pacific and Latin America are expected to witness substantial growth in blood bag consumption over the next decade. This expansion is likely to be fueled by government initiatives aimed at enhancing healthcare access and quality. Consequently, manufacturers are focusing on these emerging markets to capitalize on the growth potential, thereby shaping the future trajectory of the Blood Bag Market.

Rising Demand for Blood Products in Blood Bag Market

The Blood Bag Market is witnessing a surge in demand for blood products, which is significantly influencing market dynamics. Factors such as an aging population and an increase in surgical procedures are contributing to this rising demand. Data indicates that the need for blood transfusions is expected to rise by approximately 10% over the next few years, driven by the growing prevalence of chronic diseases. This increase necessitates a corresponding rise in the production and supply of blood bags, as they are essential for the safe storage and transportation of blood products. Consequently, manufacturers are ramping up production capacities to meet this demand, thereby propelling the Blood Bag Market forward. The interplay between demand and supply dynamics is likely to shape the future landscape of this market.

Increasing Awareness of Blood Donation in Blood Bag Market

Increasing awareness of the importance of blood donation is emerging as a significant driver in the Blood Bag Market. Campaigns aimed at educating the public about the need for blood donations are gaining traction, leading to higher participation rates in blood drives. This heightened awareness is crucial, as it directly correlates with the volume of blood collected, which in turn influences the demand for blood bags. As more individuals recognize the impact of their contributions, blood banks are experiencing a rise in donations, necessitating an increase in blood bag production. The Blood Bag Market is thus likely to benefit from this trend, as a more engaged public leads to greater blood availability and, consequently, a higher demand for blood storage solutions.

Market Segment Insights

By Type: Plastic Blood Bags (Largest) vs. Multi-Chamber Blood Bags (Fastest-Growing)

In the Blood Bag Market, Plastic Blood Bags hold the largest share, dominating the segment due to their versatility, lightweight nature, and cost-effectiveness. They are widely used for the collection and storage of blood, which makes them highly favored by healthcare providers. Multi-Chamber Blood Bags, while smaller in market share, have gained substantial traction, driven by their ability to separate different blood components effectively, which is crucial in transfusion practices.

Plastic Blood Bags (Dominant) vs. Multi-Chamber Blood Bags (Emerging)

Plastic Blood Bags are the dominant force in the Blood Bag Market, preferred for their convenience, durability, and ease of use. They come in various sizes and configurations, catering to different storage and transportation needs. Meanwhile, Multi-Chamber Blood Bags emerge as a significant innovation, facilitating the separation of blood components such as plasma, platelets, and red blood cells during collection. This capability not only enhances storage efficiency but also supports targeted therapies and transfusion practices, making them increasingly vital in hospitals and blood banks.

By Application: Whole Blood Collection (Largest) vs. Component Collection (Fastest-Growing)

The Blood Bag Market is segmented into Whole Blood Collection, Component Collection, and Blood Storage. Among these, Whole Blood Collection holds the largest share due to its widespread adoption in transfusion practices globally. This segment's dominance is attributed to the increasing demand for whole blood for various medical procedures, including surgeries and trauma care. Component Collection, however, is gaining traction and is recognized as the fastest-growing segment, driven by the rising preference for specific blood components, such as platelets and plasma, which are critical for targeted therapies. In the context of growth trends, the market is witnessing an increasing emphasis on personalized medicine, which favors Component Collection. This trend is reinforced by advancements in blood processing technologies and a rise in awareness about the benefits of using specific blood components over whole blood. Additionally, the regulatory environment is becoming more supportive of innovations, which further propels the growth of the Component Collection segment, making it a vital area of focus for industry players looking to capitalize on emerging opportunities.

Whole Blood Collection (Dominant) vs. Blood Storage (Emerging)

Whole Blood Collection is a dominant force in the Blood Bag Market, primarily due to its essential role in treating a variety of medical conditions and emergencies. It is preferred for its comprehensive nature, allowing for transfusion in critical situations without the need for further processing. However, Blood Storage represents an emerging segment, driven by the growing importance of preservation technologies that enable extended storage of blood products without compromising their viability. As advancements in storage solutions continue to evolve, this segment is gaining recognition for its potential to enhance blood bank efficiency and optimize inventory management. The interplay between the dominant Whole Blood Collection and the emerging Blood Storage segment highlights the dynamic nature of the Blood Bag Market.

By End Use: Hospitals (Largest) vs. Blood Banks (Fastest-Growing)

In the Blood Bag Market, hospitals hold a significant market share, primarily driven by their extensive use of blood bags for surgeries, trauma care, and emergency medical services. As the largest segment, hospitals continuously require a reliable supply of blood bags to meet the demands of increasing patient admissions and surgical operations. Blood banks, on the other hand, are emerging rapidly as they are essential for collecting, testing, and distributing blood products, thereby posing a robust challenge to hospitals in terms of growth dynamics. The growth in the blood bag market is significantly influenced by the rising number of blood donation campaigns and the establishment of new blood banks. Additionally, technological advancements in blood bag manufacturing, such as enhanced safety features and better preservation methods, contribute to the increasing demand within this segment. As healthcare infrastructure expands, both hospitals and blood banks are expected to grow, but blood banks are poised to exhibit the highest growth potential due to their evolving roles and increasing focus on blood management.

Hospitals (Dominant) vs. Blood Banks (Emerging)

Hospitals represent the dominant segment in the Blood Bag Market due to their critical role in healthcare services, requiring a steady supply of blood bags for various medical procedures, including surgeries and transfusions. Their established relationships with blood suppliers and a high volume of patient interactions solidify their market position. In contrast, blood banks are emerging as crucial entities responsible for the safe collection and distribution of blood products. With evolving protocols and increased emphasis on safety and efficiency, blood banks are rapidly gaining traction, benefiting from innovations in blood storage technology. Their role goes beyond mere collection; they are actively involved in educating the public about blood donation and enhancing overall community health, further establishing their importance in the blood bag ecosystem.

By Material: Polyvinyl Chloride (Largest) vs. Ethylene Vinyl Acetate (Fastest-Growing)

In the Blood Bag Market, Polyvinyl Chloride (PVC) holds the largest market share among materials used, primarily due to its established properties, durability, and cost-effectiveness. PVC blood bags are preferred for their excellent barrier properties and long shelf life, making them the go-to choice for many healthcare institutions. In contrast, Ethylene Vinyl Acetate (EVA) is emerging rapidly as a fresh material due to its flexibility and biocompatibility. This younger segment is appealing to manufacturers aiming for innovative designs and quality improvements in blood storage solutions.

Material: PVC (Dominant) vs. EVA (Emerging)

Polyvinyl Chloride (PVC) has long been the dominant material in the Blood Bag Market owing to its robustness, chemical resistance, and reliability in medical applications. Its long-standing presence has established a strong supply chain and cost advantages for manufacturers. Meanwhile, Ethylene Vinyl Acetate (EVA) is carving out a significant niche as an emerging material due to its advantageous properties, such as enhanced flexibility and increased comfort for patients. EVA's market position is bolstered by its compliance with regulatory standards, making it a popular choice for innovative blood storage solutions, especially in regions focusing on patient-centered care.

Get more detailed insights about Blood Bag Market

Regional Insights

The Blood Bag Market is experiencing promising growth across various regions, highlighting distinct dynamics in North America, Europe, APAC, South America, and MEA. In 2024, North America stands out with a valuation of 1.5 USD Billion, reflecting its majority holding in the market due to advanced healthcare infrastructure and increased awareness regarding blood donation. Europe follows with a valuation of 1.2 USD Billion in 2024, driven by regulatory support for blood collection practices and a growing geriatric population.

The APAC region is valued at 1.3 USD Billion, showcasing significant potential for market growth owing to the rising healthcare investments and increasing incidence of blood disorders.

South America, valued at 0.3 USD Billion, presents opportunities for expansion, although it remains the least dominant region, facing challenges such as varying healthcare capabilities. Lastly, the MEA region, with a value of 0.19 USD Billion in 2024, reflects emerging market potential but grapples with infrastructural hurdles. The Blood Bag Market segmentation reveals a landscape where North America and Europe dominate, while APAC displays a growing trajectory that is vital for future growth.

Blood Bag Market Regional Image

Key Players and Competitive Insights

The Blood Bag Market is witnessing significant competitive dynamics driven by various factors such as technological advancements, increasing demand for blood products, and the need for efficient blood management systems. Companies in this market are constantly innovating to enhance their product offerings, ensuring optimal safety and storage solutions for blood and its components. The competitive landscape is characterized by a mix of established players and emerging companies that are working to gain market share by introducing advanced manufacturing techniques, improving product reliability, and expanding distribution networks.
Strategic alliances, mergers and acquisitions, as well as investments in research and development, form the crux of sustaining competitive advantage in this market.
Haemonetics Corporation stands out in the Blood Bag Market due to its strong commitment to quality and innovation. The company is recognized for its advanced blood collection and transfusion technologies, which have positioned it as a leader in various segments of the market. The robust product portfolio of Haemonetics Corporation includes a range of blood bags that meet diverse healthcare needs, underscoring its adaptability to evolving industry demands. The company has a solid presence, capitalizing on its established relationships with healthcare providers and blood donation organizations.
Its focus on continuous improvement and customer satisfaction enhances its reputation and attracts ongoing partnerships in the healthcare sector. Terumo Corporation also holds a significant position in the Blood Bag Market, known for its comprehensive range of blood management solutions.
The company emphasizes innovation and quality, ensuring that its blood bags are not only compliant with regulatory standards but also designed for efficiency and safety during the collection and storage of blood. Terumo Corporation has effectively leveraged its extensive research capabilities to develop products that reduce contamination risks and enhance the overall user experience. With a commitment to sustainability and eco-friendly practices, Terumo Corporation is appealing to a broad audience, thereby solidifying its foothold in the competitive landscape of the Blood Bag Market.
The company's emphasis on strategic partnerships and expanding its geographical reach continues to play a pivotal role in its growth trajectory.

Key Companies in the Blood Bag Market include

Industry Developments

  • Q2 2024: Terumo Blood and Cell Technologies Announces FDA Clearance of IMUGARD® WB Platelet Pooling Set Terumo Blood and Cell Technologies received FDA clearance for its IMUGARD® WB Platelet Pooling Set, a new device designed to improve the safety and efficiency of blood component processing in the U.S.
  • Q1 2024: Macopharma Launches New Generation of Blood Bag Market Systems in Europe Macopharma announced the commercial launch of its next-generation blood bag systems across several European markets, aiming to enhance blood collection and storage safety.
  • Q2 2024: Fresenius Kabi Opens Expanded Blood Bag Market Manufacturing Facility in Dominican Republic Fresenius Kabi inaugurated an expanded manufacturing facility for blood bags in the Dominican Republic to increase production capacity and meet growing demand in the Americas.
  • Q3 2024: Haemonetics Announces Partnership with GPI for Advanced Blood Bag Market Solutions Haemonetics entered into a strategic partnership with GPI to co-develop and distribute advanced blood bag solutions targeting emerging markets.
  • Q2 2024: Grifols Receives CE Mark for New Blood Bag Market System Grifols obtained CE Mark approval for its newly developed blood bag system, allowing commercialization across the European Economic Area.
  • Q1 2025: Fresenius Kabi Launches Next-Generation Blood Bag Market Portfolio in Asia-Pacific Fresenius Kabi introduced a new portfolio of next-generation blood bags in the Asia-Pacific region, featuring enhanced safety and traceability features.
  • Q2 2025: Terumo BCT Expands Blood Bag Market Production Capacity in Vietnam Terumo BCT announced the expansion of its blood bag production facility in Vietnam to address rising demand in Southeast Asia.
  • Q1 2024: Baxter Appoints New President for Global Hospital Products, Including Blood Bag Market Division Baxter International named a new president to oversee its Global Hospital Products segment, which includes the company's blood bag manufacturing operations.
  • Q3 2024: JMS Singapore Receives Regulatory Approval for Innovative Blood Bag Market System JMS Singapore secured regulatory approval from Singapore's Health Sciences Authority for its innovative blood bag system, enabling local distribution.
  • Q2 2024: Poly Medicure Limited Announces Investment in New Blood Bag Market Manufacturing Plant in India Poly Medicure Limited announced a significant investment to establish a new blood bag manufacturing plant in India, aiming to boost domestic supply and exports.
  • Q1 2025: Sartorius Acquires Stake in Blood Bag Market Technology Startup Hemaclear Sartorius acquired a minority stake in Hemaclear, a startup focused on innovative blood bag technologies, to accelerate product development and commercialization.
  • Q2 2025: Fresenius Kabi Signs Long-Term Supply Agreement with Major European Blood Bank Fresenius Kabi entered into a long-term supply agreement to provide blood bags to one of Europe's largest blood banks, strengthening its presence in the region.

Future Outlook

Blood Bag Market Future Outlook

The Blood Bag Market is projected to grow at a 3.41% CAGR from 2025 to 2035, driven by increasing demand for blood transfusions and advancements in storage technologies.

New opportunities lie in:

  • Development of smart blood bag technology for real-time monitoring
  • Expansion of blood bag production facilities in emerging markets
  • Partnerships with hospitals for integrated blood management solutions

By 2035, the Blood Bag Market is expected to achieve robust growth, reflecting evolving healthcare needs.

Market Segmentation

Blood Bag Market Type Outlook

  • Plastic Blood Bags
  • Multi-Chamber Blood Bags
  • Transfer Packs

Blood Bag Market End Use Outlook

  • Hospitals
  • Blood Banks
  • Clinics

Blood Bag Market Material Outlook

  • Polyvinyl Chloride
  • Polyolefin
  • Ethylene Vinyl Acetate

Blood Bag Market Application Outlook

  • Whole Blood Collection
  • Component Collection
  • Blood Storage

Report Scope

MARKET SIZE 2024 4.49(USD Billion)
MARKET SIZE 2025 4.643(USD Billion)
MARKET SIZE 2035 6.493(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 3.41% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Terumo Corporation (JP), Haemonetics Corporation (US), Grifols S.A. (ES), Macopharma (FR), Fresenius Kabi AG (DE), Baxter International Inc. (US), Blood Systems Inc. (US), Kawasumi Laboratories Inc. (JP), Medtronic plc (IE)
Segments Covered Type, Application, End Use, Material, Regional
Key Market Opportunities Integration of advanced materials for enhanced blood preservation in the Blood Bag Market.
Key Market Dynamics Rising demand for blood components drives innovation in blood bag technology and regulatory compliance across healthcare sectors.
Countries Covered North America, Europe, APAC, South America, MEA
Leave a Comment

FAQs

What is the projected market valuation of the Blood Bag Market by 2035?

The Blood Bag Market is projected to reach a valuation of 6.493 USD Billion by 2035.

What was the market valuation of the Blood Bag Market in 2024?

In 2024, the Blood Bag Market was valued at 4.49 USD Billion.

What is the expected CAGR for the Blood Bag Market during the forecast period 2025 - 2035?

The expected CAGR for the Blood Bag Market during the forecast period 2025 - 2035 is 3.41%.

Which companies are considered key players in the Blood Bag Market?

Key players in the Blood Bag Market include Terumo Corporation, Haemonetics Corporation, Grifols S.A., and Fresenius Kabi AG.

What are the main segments of the Blood Bag Market by type?

The main segments by type include Plastic Blood Bags, Multi-Chamber Blood Bags, and Transfer Packs.

How did the valuation of Multi-Chamber Blood Bags change from 2024 to 2035?

The valuation of Multi-Chamber Blood Bags increased from 1.2 USD Billion in 2024 to a projected 1.8 USD Billion in 2035.

What applications are driving growth in the Blood Bag Market?

Growth in the Blood Bag Market is driven by applications such as Whole Blood Collection, Component Collection, and Blood Storage.

What is the projected valuation for Blood Banks in the Blood Bag Market by 2035?

The projected valuation for Blood Banks in the Blood Bag Market is expected to rise from 2.0 USD Billion in 2024 to 2.8 USD Billion by 2035.

Which materials are primarily used in the production of blood bags?

The primary materials used in the production of blood bags include Polyvinyl Chloride, Polyolefin, and Ethylene Vinyl Acetate.

What is the expected growth in the Clinics segment of the Blood Bag Market by 2035?

The Clinics segment is expected to grow from 0.99 USD Billion in 2024 to 1.59 USD Billion by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions